Literature DB >> 27190268

Original Research: Establishment of an early embolus-related cerebral injury model after cardiopulmonary bypass in miniature pigs.

Weiwei Zhang1, Guoxing Weng2, Min Li1, Shun Yu3, Jiayin Bao4, Xiying Cao1, Zhi Dou4, Huan Wang4, Haiyu Chen4.   

Abstract

Embolus-related cerebral injury is still a serious adverse event after cardiopulmonary bypass (CPB). But there is no stable animal model for basic and clinical research purposes. We chose miniature pig to establish a stable animal model of embolus-related cerebral injury after CPB and verified the validity of results by correlating the histopathological findings with those of diffusion-weighted magnetic resonance imaging (DW-MRI). Based on different treatment regimens, 24 male miniature pigs were randomly assigned into four groups: Control, CPB, embolus, and CPB-embolus groups. DW-MRI was performed before and after surgery to diagnose and locate the brain lesions. Histopathological changes in brain tissues were examined using H&E and Nissl staining. All surgical procedures were uneventful with 100% postoperative survival of pigs. Two animals in the Embolus group and six animals in the CPB-embolus group showed signs of ischemic penumbra on DW-MRI performed 6 h after surgery. Consistent with the results of DW-MRI, histopathological examination showed necrosis and ischemic lesions. In this paper, we demonstrate the feasibility and validity of a pig model of embolus-related cerebral injury associated with CPB. This model may be used in the future for basic and translational research.
© 2016 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Animal models; cardiopulmonary bypass; cerebral injury; diffusion-weighted magnetic resonance imaging; embolus; miniature pig

Mesh:

Year:  2016        PMID: 27190268      PMCID: PMC5027938          DOI: 10.1177/1535370216648804

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  18 in total

1.  Cerebral emboli detected by transcranial Doppler during cardiopulmonary bypass are not correlated with postoperative cognitive deficits.

Authors:  Rosendo A Rodriguez; Fraser D Rubens; Denise Wozny; Howard J Nathan
Journal:  Stroke       Date:  2010-08-19       Impact factor: 7.914

2.  Development of the artificial heart and lung extracorporeal blood circuit.

Authors:  J H Gibbon
Journal:  JAMA       Date:  1968-11-25       Impact factor: 56.272

3.  Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients.

Authors:  L S Rasmussen; T Johnson; H M Kuipers; D Kristensen; V D Siersma; P Vila; J Jolles; A Papaioannou; H Abildstrom; J H Silverstein; J A Bonal; J Raeder; I K Nielsen; K Korttila; L Munoz; C Dodds; C D Hanning; J T Moller
Journal:  Acta Anaesthesiol Scand       Date:  2003-03       Impact factor: 2.105

4.  Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure.

Authors:  J P Gold; M E Charlson; P Williams-Russo; T P Szatrowski; J C Peterson; P A Pirraglia; G S Hartman; F S Yao; J P Hollenberg; D Barbut
Journal:  J Thorac Cardiovasc Surg       Date:  1995-11       Impact factor: 5.209

5.  Preliminary report of the effects of complement suppression with pexelizumab on neurocognitive decline after coronary artery bypass graft surgery.

Authors:  Joseph P Mathew; Stanton K Shernan; William D White; Jane C K Fitch; John C Chen; Leonard Bell; Mark F Newman
Journal:  Stroke       Date:  2004-08-26       Impact factor: 7.914

6.  Neurocognitive impairment after off-pump and on-pump coronary artery bypass graft surgery - an Iranian experience.

Authors:  Mehdi Farhoudi; Kaveh Mehrvar; Abbas Afrasiabi; Rezayat Parvizi; Ahmad Ali Khalili; Babak Nasiri; Khosrow Hashemzadeh; Kamyar Ghabili
Journal:  Neuropsychiatr Dis Treat       Date:  2010-11-19       Impact factor: 2.570

7.  Postoperative neurocognitive dysfunction in elderly patients after xenon versus propofol anesthesia for major noncardiac surgery: a double-blinded randomized controlled pilot study.

Authors:  Jan Höcker; Claudia Stapelfeldt; Jörn Leiendecker; Patrick Meybohm; Robert Hanss; Jens Scholz; Berthold Bein
Journal:  Anesthesiology       Date:  2009-05       Impact factor: 7.892

8.  Effects of preoperative hypoxia on white matter injury associated with cardiopulmonary bypass in a rodent hypoxic and brain slice model.

Authors:  Kota Agematsu; Ludmila Korotcova; Joseph Scafidi; Vittorio Gallo; Richard A Jonas; Nobuyuki Ishibashi
Journal:  Pediatr Res       Date:  2014-01-31       Impact factor: 3.756

9.  The role of microclot formation in an acute subarachnoid hemorrhage model in the rabbit.

Authors:  Lukas Andereggen; Volker Neuschmelting; Michael von Gunten; Hans Rudolf Widmer; Javier Fandino; Serge Marbacher
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

Review 10.  Risk Factors Associated with Cognitive Decline after Cardiac Surgery: A Systematic Review.

Authors:  Nikil Patel; Jatinder S Minhas; Emma M L Chung
Journal:  Cardiovasc Psychiatry Neurol       Date:  2015-09-30
View more
  3 in total

1.  Dexmedetomidine reduces the neuronal apoptosis related to cardiopulmonary bypass by inhibiting activation of the JAK2-STAT3 pathway.

Authors:  Yanhua Chen; Xu Zhang; Bingdong Zhang; Guodong He; Lifang Zhou; Yubo Xie
Journal:  Drug Des Devel Ther       Date:  2017-09-26       Impact factor: 4.162

2.  Effects of TLR3 and TLR9 Signaling Pathway on Brain Protection in Rats Undergoing Sevoflurane Pretreatment during Cardiopulmonary Bypass.

Authors:  Zhou Nan; Zhou Jin; Cao Huijuan; Zhang Tiezheng; Chen Keyan
Journal:  Biomed Res Int       Date:  2017-12-27       Impact factor: 3.411

3.  Cardiopulmonary bypass duration is an independent predictor of adverse outcome in surgical repair for acute type A aortic dissection.

Authors:  Kai Zhang; Xu-Dong Pan; Song-Bo Dong; Jun Zheng; Shang-Dong Xu; Yong-Min Liu; Jun-Ming Zhu; Li-Zhong Sun
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.